Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
WS07 - LATAM Workshop
- Type: Workshop
- Track: N/A
- Presentations: 8
- Moderators:Clarissa Mathias
- Coordinates: 8/06/2022, 15:00 - 16:30, Lehar 2
-
+
WS07.08 - Ancestry and Somatic Mutations in Lung Cancer in Latin America
15:52 - 16:02 | Author(s): Ticiana Leal
- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 171
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.02-019 - Phase 1/2 Study of BLU-701, a Highly Selective EGFR Inhibitor, in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
Author(s): Alexander Spira- Abstract
Loading...
-
+
EP14.03 - Small Cell Lung Cancer and Neuro-endocrine Tumors - RT
- Type: E-Poster
- Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - RT
- Presentations: 5
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP14.03-003 - Phase I Study of Palliative Radiotherapy with Lurbinectedin in Patients with Extensive Stage Small Cell Lung Cancer
Author(s): Neal Sean Mccall- Abstract
Loading...
-
+
P1.10 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- Type: Regular Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- Presentations: 4
- Coordinates: 8/07/2022, 17:00 - 19:00, Exhibit Hall - Hall B
-
+
P1.10-04 - Impact of Radiation Dose to the Immune Cells in Unresectable or Stage III Non-Small Cell Lung Cancer in the Durvalumab Era
Author(s): Neal Sean Mccall- Abstract
Loading...
-
+
MA06 - Resectable and Unresectable Locally Advanced Lung Cancer
- Type: Mini Oral
- Track: Locally Advanced Non-small Cell Lung Cancer
- Presentations: 13
- Moderators:Saulius Cicenas
- Coordinates: 8/08/2022, 12:15 - 13:15, Lehar 1
-
+
MA06.05 - Consolidation Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation for Patients with Unresectable Stage III NSCLC
12:27 - 12:32 | Author(s): Greg Andrew Durm
- Abstract
Loading...
-
+
P2.02 - Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
- Presentations: 3
- Coordinates: 8/08/2022, 17:15 - 19:15, Exhibit Hall - Hall B
-
+
P2.02-02 - A Phase 2 Study of MLN4924 (Pevonedistat) in Combination with Carboplatin and Paclitaxel in Advanced NSCLC Previously Treated with Immunotherapy
Author(s): Ralph Linwood Millett- Abstract
Loading...
-
+
P2.04 - Nursing and Allied Health Professionals
- Type: Regular Poster
- Track: Nursing and Allied Health Professionals
- Presentations: 4
- Coordinates: 8/08/2022, 17:15 - 19:15, Exhibit Hall - Hall B
-
+
P2.04-05 - Is Opioid Use in the Management of Stage III Non-Small Cell Lung Cancer Patients Necessary?
Author(s): Ulrike Gorgens- Abstract
Loading...
-
+
OA15 - Patient Selection in Advanced NSCLC Immunotherapy
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 10
- Moderators:Pilar Garrido
- Coordinates: 8/09/2022, 14:30 - 15:30, Hall C7
-
+
OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer
15:02 - 15:12 | Author(s): Delvys Rodriguez-Abreu
- Abstract
Loading...
